HomeCompareXVIPY vs PM

XVIPY vs PM: Dividend Comparison 2026

XVIPY yields 30.58% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XVIPY wins by $87.3K in total portfolio value
10 years
XVIPY
XVIPY
● Live price
30.58%
Share price
$6.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136.9K
Annual income
$18,414.99
Full XVIPY calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — XVIPY vs PM

📍 XVIPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXVIPYPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XVIPY + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XVIPY pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XVIPY
Annual income on $10K today (after 15% tax)
$2,599.39/yr
After 10yr DRIP, annual income (after tax)
$15,652.74/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, XVIPY beats the other by $13,534.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XVIPY + PM for your $10,000?

XVIPY: 50%PM: 50%
100% PM50/50100% XVIPY
Portfolio after 10yr
$93.2K
Annual income
$10,453.51/yr
Blended yield
11.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

XVIPY
No analyst data
Altman Z
4.9
Piotroski
6/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XVIPY buys
0
PM buys
0
No recent congressional trades found for XVIPY or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXVIPYPM
Forward yield30.58%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$136.9K$49.6K
Annual income after 10y$18,414.99$2,492.02
Total dividends collected$94.1K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: XVIPY vs PM ($10,000, DRIP)

YearXVIPY PortfolioXVIPY Income/yrPM PortfolioPM Income/yrGap
1← crossover$13,758$3,058.10$11,648$408.29+$2.1KXVIPY
2$18,653$3,932.12$13,589$495.90+$5.1KXVIPY
3$24,941$4,982.42$15,877$603.21+$9.1KXVIPY
4$32,914$6,226.19$18,580$734.88+$14.3KXVIPY
5$42,896$7,678.77$21,781$896.75+$21.1KXVIPY
6$55,252$9,353.04$25,578$1,096.12+$29.7KXVIPY
7$70,379$11,258.95$30,092$1,342.17+$40.3KXVIPY
8$88,708$13,403.14$35,470$1,646.46+$53.2KXVIPY
9$110,707$15,788.69$41,892$2,023.58+$68.8KXVIPY
10$136,871$18,414.99$49,578$2,492.02+$87.3KXVIPY

XVIPY vs PM: Complete Analysis 2026

XVIPYStock

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Full XVIPY Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this XVIPY vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XVIPY vs SCHDXVIPY vs JEPIXVIPY vs OXVIPY vs KOXVIPY vs MAINXVIPY vs MOXVIPY vs BTIXVIPY vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.